Open AccessSurvival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017
Author(s) -
Alexandra Albertsson-Lindblad,
Þorgerður Pálsdóttir,
Karin E. Smedby,
Caroline E. Weibull,
Ingrid Glimelius,
Mats Jerkeman
Publication year - 2021
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2021.279037
Subject(s) - bendamustine , mantle cell lymphoma , regimen , medicine , chop , oncology , rituximab , lymphoma
Not available.